COVID‐19 is characterized by excessive production of multiple proinflammatory cytokines [17, 18] and patients with severe COVID‐19 have a highly impaired IFN type I signature, in particular, reduced IFN‐α production and activity [6]. The gene discussed is IFNA1; the disease is COVID-19.